2026/2027 INDIANA QMA INSULIN ADMINISTRATION EXAM LATEST
ACTUAL EXAM TEST BANK| COMPLETE 200 REAL EXAM QUESTIONS
AND CORRECT VERIFIED ANSWERS/ ALREADY GRADED A+
Question 1
Prior to administering insulin at a licensed health facility in Indiana,
what must the Qualified Medication Aide (QMA) ensure regarding their
authorization?
• A. They can administer insulin independently without facility
oversight.
• B. They must be supervised by an RN or have responsibility
delegated by an RN based on a competency assessment.
• C. They only need a standard CNA certification.
• D. They must complete an annual practical evaluation
administered by the federal government.
• Correct Answer: B
• Rationale: According to Indiana regulations, the QMA must either
be supervised by an RN during insulin administration or have the
responsibility delegated by the RN based on a formal competency
assessment.
Question 2
Where is the pancreas located within the human body?
• A. Lower right quadrant of the abdominal cavity
• B. Upper abdomen, directly behind the stomach
• C. Inside the thoracic cavity alongside the lungs
, • D. Embedded within the lower lobes of the liver
• Correct Answer: B
• Rationale: The pancreas is an endocrine and exocrine gland
situated transversely in the upper abdomen, directly posterior to
the stomach.
Question 3
Which specialized cluster of cells within the pancreas is responsible for
producing and secreting insulin and glucagon?
• A. Acinar cells
• B. Islets of Langerhans
• C. Kupffer cells
• D. Renal corpuscles
• Correct Answer: B
• Rationale: The Islets of Langerhans contain specialized cells (alpha
and beta cells) that synthesize and secrete glucagon and insulin to
regulate blood glucose levels.
Question 4
Which of the following insulins is classified as rapid-acting?
• A. Novolin N
• B. Lantus (insulin glargine)
• C. Humalog (insulin lispro)
• D. Regular insulin
, • Correct Answer: C
• Rationale: Humalog (insulin lispro) is a rapid-acting analog
engineered to start working very quickly to cover mealtime
glucose spikes.
Question 5
Which insulin type appears cloudy in a vial and requires gentle rolling
prior to drawing up a dose?
• A. Regular insulin
• B. Humalog
• C. Lantus
• D. Novolin N (NPH)
• Correct Answer: D
• Rationale: Intermediate-acting NPH insulin (such as Novolin N) is a
suspension that settles over time, appearing cloudy, and must be
gently mixed before administration.
Question 6
What is the primary characteristic of long-acting insulin (such as
Lantus)?
• A. It peaks sharply within 15 to 30 minutes of injection.
• B. It provides a steady, baseline level of insulin over 24 hours
without a pronounced peak.
• C. It must be administered exactly 30 minutes after every main
meal.
, • D. It is formulated to be mixed with rapid-acting insulin in the
same syringe.
• Correct Answer: B
• Rationale: Long-acting insulins mimic basal insulin secretion,
providing a continuous flat baseline profile throughout the day
without a defined peak.
Question 7
What needle length is commonly recommended and correct for
subcutaneous insulin injections?
• A. 1 to 1.5 inches
• B. 2 inches
• C. 1/4 to 5/8 inch
• D. 3 inches
• Correct Answer: C
• Rationale: Subcutaneous injections require short, fine needles
(typically 1/4 to 5/8 inch) to deposit medication into the fatty
tissue layer beneath the dermis.
Question 8
At what angle should a standard subcutaneous insulin injection typically
be administered, depending on the resident's body tissue and needle
length?
• A. Exactly 15 degrees flat
• B. 45 to 90 degrees
ACTUAL EXAM TEST BANK| COMPLETE 200 REAL EXAM QUESTIONS
AND CORRECT VERIFIED ANSWERS/ ALREADY GRADED A+
Question 1
Prior to administering insulin at a licensed health facility in Indiana,
what must the Qualified Medication Aide (QMA) ensure regarding their
authorization?
• A. They can administer insulin independently without facility
oversight.
• B. They must be supervised by an RN or have responsibility
delegated by an RN based on a competency assessment.
• C. They only need a standard CNA certification.
• D. They must complete an annual practical evaluation
administered by the federal government.
• Correct Answer: B
• Rationale: According to Indiana regulations, the QMA must either
be supervised by an RN during insulin administration or have the
responsibility delegated by the RN based on a formal competency
assessment.
Question 2
Where is the pancreas located within the human body?
• A. Lower right quadrant of the abdominal cavity
• B. Upper abdomen, directly behind the stomach
• C. Inside the thoracic cavity alongside the lungs
, • D. Embedded within the lower lobes of the liver
• Correct Answer: B
• Rationale: The pancreas is an endocrine and exocrine gland
situated transversely in the upper abdomen, directly posterior to
the stomach.
Question 3
Which specialized cluster of cells within the pancreas is responsible for
producing and secreting insulin and glucagon?
• A. Acinar cells
• B. Islets of Langerhans
• C. Kupffer cells
• D. Renal corpuscles
• Correct Answer: B
• Rationale: The Islets of Langerhans contain specialized cells (alpha
and beta cells) that synthesize and secrete glucagon and insulin to
regulate blood glucose levels.
Question 4
Which of the following insulins is classified as rapid-acting?
• A. Novolin N
• B. Lantus (insulin glargine)
• C. Humalog (insulin lispro)
• D. Regular insulin
, • Correct Answer: C
• Rationale: Humalog (insulin lispro) is a rapid-acting analog
engineered to start working very quickly to cover mealtime
glucose spikes.
Question 5
Which insulin type appears cloudy in a vial and requires gentle rolling
prior to drawing up a dose?
• A. Regular insulin
• B. Humalog
• C. Lantus
• D. Novolin N (NPH)
• Correct Answer: D
• Rationale: Intermediate-acting NPH insulin (such as Novolin N) is a
suspension that settles over time, appearing cloudy, and must be
gently mixed before administration.
Question 6
What is the primary characteristic of long-acting insulin (such as
Lantus)?
• A. It peaks sharply within 15 to 30 minutes of injection.
• B. It provides a steady, baseline level of insulin over 24 hours
without a pronounced peak.
• C. It must be administered exactly 30 minutes after every main
meal.
, • D. It is formulated to be mixed with rapid-acting insulin in the
same syringe.
• Correct Answer: B
• Rationale: Long-acting insulins mimic basal insulin secretion,
providing a continuous flat baseline profile throughout the day
without a defined peak.
Question 7
What needle length is commonly recommended and correct for
subcutaneous insulin injections?
• A. 1 to 1.5 inches
• B. 2 inches
• C. 1/4 to 5/8 inch
• D. 3 inches
• Correct Answer: C
• Rationale: Subcutaneous injections require short, fine needles
(typically 1/4 to 5/8 inch) to deposit medication into the fatty
tissue layer beneath the dermis.
Question 8
At what angle should a standard subcutaneous insulin injection typically
be administered, depending on the resident's body tissue and needle
length?
• A. Exactly 15 degrees flat
• B. 45 to 90 degrees
